Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
Persistently supraphysiologic IGF-1 is associated with insulin resistance, edema and a theoretical tumor-growth concern
discovered that the combination of metformin and insulin led to a significant increase in the expression of growth factor-associated proteins, impacting the proliferation of endometrial stromal cells (Ferreira et al., 2022)
Moreover, the activation was completely abolished when using the double motif-mutated luciferase plasmid, MutAB (Fig
SCFAs involving in acetate, propionate, and butyrate are the primary metabolites produced by gut microbiota through dietary fiber fermentation
We investigated if oral administration of liposomal GSH is effective at enhancing GSH levels in vivo